P. Emery

发表

Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions

M. D. de Wit, D. M. van der Heijde, V. Bykerk, 2012, Annals of the rheumatic diseases.

2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.

D. Symmons, D. Felson, P. Tak, 2010, Arthritis and rheumatism.

Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis

F. Breedveld, D. M. van der Heijde, P. Tak, 2011, Annals of the rheumatic diseases.

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

R. Landewé, V. Bykerk, J. Gottenberg, 2017 .

How does functional disability in early rheumatoid arthritis (RA) affect patients and their lives? Results of 5 years of follow-up in 732 patients from the Early RA Study (ERAS)

P. Emery, A. Young, A. Gough, 2000, Rheumatology.

EULAR RECOMMENDATIONS FOR THE MANAGEMENT OF RHEUMATOID ARTHRITIS WITH SYNTHETIC AND BIOLOGICAL DISEASE-MODIFYING ANTIRHEUMATIC DRUGS: 2019 UPDATE

R. Landewé, J. Gottenberg, C. Codreanu, 2020 .

Access to disease modifying treatments for rheumatoid arthritis patients

P. Lipsky, D. Furst, P. Emery, 1999, Annals of the rheumatic diseases.

Which patients stop working because of rheumatoid arthritis? Results of five years' follow up in 732 patients from the Early RA Study (ERAS)

E. Kulinskaya, P. Emery, A. Young, 2002, Annals of the rheumatic diseases.

Updated consensus statement on biological agents, specifically tumour necrosis factor α (TNFα) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2005

P. Mease, J. Smolen, G. Burmester, 2004 .

Updated consensus statement on biological agents, specifically tumour necrosis factor alpha (TNFalpha) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2004.

M. Dougados, D. Furst, P. Emery, 2004, Annals of the rheumatic diseases.

Extended report: Evidence for treating rheumatoid arthritis to target: results of a systematic literature search

D. Heijde, R. Knevel, D. Aletaha, 2010 .

2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.

D. Symmons, D. Felson, P. Tak, 2010, Arthritis and rheumatism.

The European ankylosing spondylitis infliximab cohort (EASIC): a European multicentre study of long term outcomes in patients with ankylosing spondylitis treated with infliximab.

M. Dougados, P. Geusens, R. Landewé, 2011, Clinical and experimental rheumatology.

Impact of T-cell costimulation modulation in patients with undifferentiated inflammatory arthritis or very early rheumatoid arthritis: a clinical and imaging study of abatacept (the ADJUST trial)

M. Dougados, H. Genant, I. Logeart, 2009, Annals of the rheumatic diseases.